Glycopyrronium
Back to searchMolecule Structure
Scientific Name
Glycopyrronium
Description of the Drug
Glycopyrronium is an anticholinergic agent used to treat hyperhidrosis, severe drooling, COPD, used with other medications to treat ulcers, and used in anesthesia.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00986
http://www.drugbank.ca/drugs/DB00986
Brand Name(s)
Not Available
Company Owner(s)
Watson Laboratories Inc, Nivagen Pharmaceuticals Inc, American Regent Inc, Amneal Eu Ltd, Novartis Pharmaceuticals Corp, Zydus Pharmaceuticals Usa Inc, Aurolife Pharma Llc, Prinston Pharmaceutical Inc, Casper Pharma Llc, Alembic Labs Llc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Muscarinic acetylcholine receptor M1 | SINGLE PROTEIN | ANTAGONIST | CHEMBL216 |
| Muscarinic acetylcholine receptor M3 | SINGLE PROTEIN | ANTAGONIST | CHEMBL245 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL133002 | ||||||
| PharmGKB | PA164754882 | ||||||
| Human Metabolome Database | HMDB0015121 | ||||||
| DrugBank | DB00986 | ||||||
| PubChem | 3494 | ||||||
| NMRShiftDB | 60078627 | ||||||
| LINCS | LSM-5163 | ||||||
| Nikkaji | J239.170H | ||||||
| BindingDB | 50417445 | ||||||
| EPA CompTox Dashboard | DTXSID2048165 | ||||||
| DrugCentral | 4302 | ||||||
| Guide to Pharmacology | 7459 | ||||||
| rxnorm | SEEBRI | GLYCOPYRRONIUM TOSYLATE | ROBINUL | QBREXZA | CUVPOSA | GLYCOPYRROLATE | GLYCOPYRRONIUM |
| ChEBI | 94449 |
